**Core Concept**
Alkylating agents are a class of chemotherapy drugs that work by causing cross-linking of DNA strands, thereby interfering with DNA replication and cell division. This leads to cell death, primarily in rapidly dividing cells such as cancer cells.

**Why the Correct Answer is Right**
The mechanism of action of alkylating agents involves the transfer of an alkyl group to the DNA molecule, resulting in the formation of DNA cross-links and DNA-protein cross-links. This damage triggers the activation of DNA repair enzymes, but if the damage is too extensive, it can lead to cell death. The most commonly affected sites are the O6 position of guanine and the N7 position of guanine, which are critical for DNA replication and transcription.

**Why Each Wrong Option is Incorrect**
**Option A:** Bone marrow suppression is a common side effect of many chemotherapy agents, including alkylating agents, but it is not the primary mechanism of action.
**Option B:** While alkylating agents can cause damage to the bone marrow, leading to myelosuppression, this is not the correct answer as it describes a side effect rather than the primary mechanism of action.
**Option C:** Alkylating agents do not primarily work by inhibiting topoisomerase enzymes, which are targeted by a different class of chemotherapy agents.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that alkylating agents can cause secondary malignancies, particularly acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), due to the mutagenic effects of these drugs.

**Correct Answer: D. DNA cross-linking**